Avalo Therapeutics AVTX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Avalo Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Avalo Therapeutics’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's gross margin?
- Avalo Therapeutics (AVTX) reported gross margin of 182% in Q3 2024.
- How has Avalo Therapeutics's gross margin changed year-over-year?
- Avalo Therapeutics's gross margin increased by 3201.5% year-over-year, from 5.5% to 182%.
- What is the long-term trend for Avalo Therapeutics's gross margin?
- Over 3 years (2020 to 2023), Avalo Therapeutics's gross margin has grown at a -29.7% compound annual growth rate (CAGR), from 95.5% to 33.2%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.